ARGO THERAPEUTICS
Argo Therapeutics is a developer of inventive therapeutics to deliver a cure for neurological disorders. The company offers a pipeline of drug candidates that target a multi-acting nuclear receptor Nurr1 which is required for the development of dopaminergic neurons.
ARGO THERAPEUTICS
Social Links:
Industry:
Life Science Medical Neuroscience Therapeutics
Founded:
2020-01-01
Address:
Allschwil, Basel-Landschaft, Switzerland
Country:
Switzerland
Website Url:
http://www.argo-therapeutics.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
German Server Location
Similar Organizations
Afferent Technologies
Afferent Technologies is a developer of novel instrumentation for neuroscience and neurology.
Rewind Therapeutics
Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.
Sense Neuro Diagnostics
Sense Neuro Diagnostics is a developer of non-invasive medical devices for neurological conditions.
Stem Cell Medicine
Stem Cell Medicine is a developer of cellular therapies in tissue repair and for the treatment of inflammatory disorders.
Theraptosis
Theraptosis is a biopharmaceutical company that designs and develops various drugs for cancer and neurodegenerative diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.argo-therapeutics.com Semrush global rank: 11.84 M Semrush visits lastest month: 143
- Host name: 185.221.106.187
- IP address: 185.221.106.187
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Argo Therapeutics"
Argo Therapeutics - PitchBook
Argo Therapeutics was founded in 2020. Where is Argo Therapeutics headquartered? Argo Therapeutics is headquartered in Allschwil, Switzerland. What industry is Argo Therapeutics in? Argo Therapeutics’s primary industry …See details»
Argo Biopharma
Argo Biopharma was established in April 2021, focusing on the development of a new generation of siRNA drugs. It was founded by several returnee scientists with rich experience in siRNA drug development. About. ... a Novel RNAi …See details»
Argo Therapeutics GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Argo Therapeutics GmbH of Basel, BASEL-STADT. Get the latest business insights from Dun & …See details»
Argo Therapeutics - Company Profile - Tracxn
Argo Therapeutics - Developer of therapeutics for neurological disorders. Raised funding from 1 investor. Founded by Alexander Breidenbach and Athanasios Spathis in the year 2020. Argo …See details»
Argo Therapeutics - Crunchbase
Argo Therapeutics is a developer of inventive therapeutics to deliver a cure for neurological disorders.See details»
Argo Biopharma - Company Profile - Tracxn
Dec 28, 2024 Argo Biopharma - Developer of oligonucleotide therapeutics for various diseases. Raised a total funding of $104M over 2 rounds from 7 investors. Founded by Dongxu Shu, …See details»
Argo Therapeutics - Updates, News, Events, Signals & Triggers
Mar 17, 2024 Argo Therapeutics is a developer of inventive therapeutics to deliver a cure for neurological disorders. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Novartis–Argo Biopharma: RNAi therapeutics, 202401– two license …
Jan 7, 2024 Argo has developed industry-leading RNAi platform technology named RADS (RNAi molecules with superior Activity, Duration and Safety), which embodies Argo's technological …See details»
Argo Biopharma | Biotechnology - The Pharmaletter
Jan 9, 2024 Since then, Argo has developed industry-leading RNAi platform technology named RADS (RNAi molecules with superior Activity, Duration and Safety). As of Q1 2023, Argo's …See details»
Argo Signs $4.2 Billion Agreement Selling Four RNA
Jan 8, 2024 Shanghai Argo Biopharma entered two agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. In the first …See details»
Argos Therapeutics, Inc. Company Profile - Dun & Bradstreet
Argos Therapeutics, Inc. Website. Get a D&B Hoovers Free Trial. Overview Doing Business As: (A Development Stage Company) Company Description: Argos aimed to be a faithful servant …See details»
Argo Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Argo Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 5. Monthly Visits 143. …See details»
Shanghai Argo Announces Multi-Program RNAi Licenses and …
Jan 8, 2024 "We believe the cardiovascular programs that Argo has developed using its state-of-the-art RNAi platform complement the Novartis pipeline of RNA-based therapeutics," said …See details»
Shanghai Argo Announces Multi-Program RNAi Licenses ... - Argo …
SHANGHAI, Jan. 07, 2024 /PRNewswire/ -- Shanghai Argo Biopharmaceutical Co., Ltd. ("Argo"), a biotechnology company focused on the discovery and development of next-generation RNAi …See details»
Argos Therapeutics (ARGSQ) Stock Price, News & Analysis
Oct 10, 2019 The company also develops AGS-004, which is in Phase II clinical trials for the treatment of human immunodeficiency virus. The company was formerly known as Merix …See details»
Argos Therapeutics Company Profile 2025: Valuation, Investors ...
Argos Therapeutics General Information Description. Developer of personalized immunotherapies intended for the treatment of cancer and infectious diseases. The company utilizes its …See details»
Argo Therapeutics - Contacts, Employees, Board Members
Organization. Argo Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Argo …See details»
Argos Therapeutics - Pharmstd Ventures
Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and …See details»
Argos Therapeutics - Crunchbase Company Profile & Funding
Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The …See details»
CARGO Therapeutics Provides Corporate Update and Anticipated …
Jan 10, 2025 About CARGO Therapeutics CARGO Therapeutics, Inc. is a clinical-stage biotechnology company positioned to advance next-generation, best-in-class, and potentially …See details»